Aliases & Classifications for Meniere Disease

MalaCards integrated aliases for Meniere Disease:

Name: Meniere Disease 56 12 52 25 36 43 39 17 71
Meniere's Disease 12 52 25 42 15
Ménière's Disease 74 52 25 6
Otogenic Vertigo 12 25
Ménière Disease 25 32
Primary Endolymphatic Hydrops 25
Meniere's Syndrome 25
Ménière's Vertigo 25
Auditory Vertigo 25
Menieres Disease 54
Mnire's Vertigo 12
Vertigo, Aural 71
Aural Vertigo 25

Characteristics:

OMIM:

56
Miscellaneous:
incomplete penetrance
onset usually between 30 and 50 years of age
prevalence of 0.5 to 1 in 1,000

Inheritance:
autosomal dominant


HPO:

31
meniere disease:
Inheritance autosomal dominant inheritance
Onset and clinical course incomplete penetrance


Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Ear diseases


External Ids:

Disease Ontology 12 DOID:9849
OMIM 56 156000
KEGG 36 H01495
ICD9CM 34 386.0 386.00
MeSH 43 D008575
SNOMED-CT 67 13445001
ICD10 32 H81.0 H81.09
MedGen 41 C0025281
UMLS 71 C0025281 C1527320

Summaries for Meniere Disease

Genetics Home Reference : 25 Ménière disease is a disorder of the inner ear that affects balance and hearing. This condition is characterized by sudden episodes of extreme dizziness (vertigo), a roaring sound in the ears (tinnitus), a feeling of pressure or fullness in the ears, and fluctuations in hearing. Episodes are often associated with nausea and vomiting, and they can severely disrupt activities of daily living. The episodes associated with Ménière disease generally last several hours. Studies suggest that episodes can be triggered by stress, tiredness (fatigue), emotional upset, illness, and dietary factors. The timing of these episodes is unpredictable; affected individuals may experience a cluster of episodes within a short period, followed by months or years without any symptoms. Ménière disease usually appears in adulthood, most often in a person's 40s or 50s. It is much less common in children and young adults. The symptoms of the disorder typically begin in one ear, although they may later involve both ears. Some people with Ménière disease have no symptoms of the disorder between episodes, particularly in the early stages of the disease. Over time, however, many affected individuals develop ongoing problems with unsteadiness, tinnitus, and a feeling of fullness in the ears. Additionally, permanent hearing loss eventually develops in many people with this disorder.

MalaCards based summary : Meniere Disease, also known as meniere's disease, is related to inner ear disease and neuroma, and has symptoms including vertigo, tinnitus and snoring. An important gene associated with Meniere Disease is FAM136A (Family With Sequence Similarity 136 Member A), and among its related pathways/superpathways are Nanog in Mammalian ESC Pluripotency and Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds. The drugs Sodium citrate and Betahistine have been mentioned in the context of this disorder. Affiliated tissues include testes, bone and brain, and related phenotypes are hearing impairment and vertigo

Disease Ontology : 12 A vestibular disease characterized by vertigo, low-pitched tinnitus and hearing loss.

NIH Rare Diseases : 52 Meniere's disease is an abnormality of the inner ear. Signs and symptoms may include disabling vertigo or severe dizziness lasting from minutes to hours; tinnitus or a roaring sound in the ears; fluctuating hearing loss ; and the sensation of pressure or pain in the affected ear. A small percentage of people have drop attacks . The disorder usually affects only one ear, but some people develop symptoms in both ears many years after their initial diagnosis. Although the exact cause of Meniere's disease is unknown, the symptoms are thought to be associated with a change in fluid volume within a portion of the inner ear known as the labyrinth. Treatment may include medications or surgery depending on the severity of the condition.

OMIM : 56 Meniere disease is a chronic illness characterized by intermittent episodes of vertigo lasting from minutes to hours, with fluctuating sensorineural hearing loss, tinnitus, and aural pressure (Sajjadi and Paparella, 2008). (156000)

MedlinePlus : 42 Meniere's disease is a disorder of the inner ear. It can cause severe dizziness, a roaring sound in your ears called tinnitus, hearing loss that comes and goes and the feeling of ear pressure or pain. It usually affects just one ear. It is a common cause of hearing loss. Attacks of dizziness may come on suddenly or after a short period of tinnitus or muffled hearing. Some people have single attacks of dizziness once in a while. Others may have many attacks close together over several days. Some people with Meniere's disease have "drop attacks" during which the dizziness is so bad they lose their balance and fall. Scientists don't yet know the cause. They think that it has to do with the fluid levels or the mixing of fluids in the canals of your inner ear. Doctors diagnose it based on a physical exam and your symptoms. A hearing test can check to see how it has affected your hearing. There is no cure. Treatments include medicines to control dizziness, limiting salt in your diet, and taking water pills. A device that fits into the outer ear and delivers air pulses to the middle ear can help. Severe cases may require surgery. NIH: National Institute on Deafness and Other Communication Disorders

KEGG : 36 Meniere disease is an inner ear disorder characterized by episodic vertigo attacks, sensorineural hearing loss, tinnitus, and aural fullness. Prevailing theories on its pathogenesis point to endolymphatic hydrops as one derangement responsible for producing dysfunction within the cochlea and peripheral vestibular apparatus. Although the familial clustering and the geographical and racial differences in incidence suggest a certain role for genetic factors in the development of Meniere disease, no convincing evidence for an association with any gene exists, at present.

Wikipedia : 74 Meniere's disease (MD) is a disorder of the inner ear that is characterized by episodes of feeling like... more...

Related Diseases for Meniere Disease

Diseases related to Meniere Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 209, show less)
# Related Disease Score Top Affiliating Genes
1 inner ear disease 31.0 MIP COCH AQP6 AQP1
2 neuroma 30.8 AQP6 AQP4 AQP1
3 vestibular disease 30.8 FAM136A COCH AQP2
4 deafness, autosomal dominant 9 30.6 FAM136A COCH
5 acoustic neuroma 30.5 AQP6 AQP4 AQP1
6 peripheral vertigo 30.5 FAM136A DTNA COCH AQP2 AQP1
7 hydrops, lactic acidosis, and sideroblastic anemia 30.3 MIP AQP4
8 deafness, autosomal dominant 15 30.3 FAM136A COCH
9 intraocular pressure quantitative trait locus 29.8 PTGFR MIP COCH AQP4 AQP1
10 bone inflammation disease 29.2 TLR10 PTPN22 HLA-DRB1
11 alopecia areata 29.2 PTPN22 MIF HLA-DRB1 HLA-C
12 celiac disease 1 28.7 TLR10 PTPN22 HLA-DRB1 HLA-C
13 active cochleovestibular meniere's disease 11.3
14 active vestibular meniere's disease 11.3
15 active cochlear meniere's disease 11.3
16 kanzaki disease 11.3
17 branchiootic syndrome 1 10.6
18 deafness, autosomal dominant 28 10.4 FAM136A COCH
19 idiopathic edema 10.4 AQP2 AQP1
20 otosclerosis 10.4
21 subependymoma 10.4 AQP4 AQP1
22 sensorineural hearing loss 10.4
23 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.4
24 migraine with or without aura 1 10.4
25 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.4
26 central pontine myelinolysis 10.3 AQP4 AQP2 AQP1
27 aplasia of lacrimal and salivary glands 10.3 MIP AQP5
28 diabetes insipidus 10.3 MIP AQP3 AQP2
29 facial paralysis 10.3
30 syphilis 10.3
31 dysferlinopathy 10.3 MIP AQP4 AQP1
32 pathologic nystagmus 10.3
33 corticosteroid allergy 10.3 AQP4 AQP3
34 auditory system disease 10.3
35 labyrinthitis 10.2
36 sleep apnea 10.2
37 ataxia and polyneuropathy, adult-onset 10.2
38 autoimmune inner ear disease 10.2
39 head injury 10.2
40 headache 10.2
41 oligohydramnios 10.2 AQP7 AQP3 AQP1
42 type 1 diabetes mellitus 18 10.2 SLC44A2 PTPN22
43 hearing loss, noise-induced 10.2
44 syncope 10.2
45 intracranial hypertension, idiopathic 10.2 AQP4 AQP1
46 inappropriate adh syndrome 10.2 AQP4 AQP3 AQP2 AQP1
47 benign paroxysmal positional nystagmus 10.2
48 hypothyroidism 10.1
49 herpes simplex 10.1
50 age-related hearing loss 10.1
51 apnea, obstructive sleep 10.1
52 trigeminal neuralgia 10.1
53 cholesteatoma of middle ear 10.1
54 herpes zoster 10.1
55 brain edema 10.1 MIP AQP5 AQP4 AQP1
56 rheumatoid vasculitis 10.1 MIF HLA-DRB1
57 obstructive hydrocephalus 10.1 AQP4 AQP1
58 rheumatoid factor-negative juvenile idiopathic arthritis 10.1 PTPN22 HLA-DRB1
59 hydrarthrosis 10.1 MIP AQP7 AQP3 AQP1
60 palindromic rheumatism 10.1 PTPN22 HLA-DRB1
61 otitis media 10.0
62 arachnoid cysts, intracranial 10.0
63 anxiety 10.0
64 leukemia, acute lymphoblastic 3 10.0
65 mumps 10.0
66 bell's palsy 10.0
67 gastroenteritis 10.0
68 neuronitis 10.0
69 chickenpox 10.0
70 hypoglycemia 10.0
71 47,xyy 10.0
72 diffuse cutaneous systemic sclerosis 10.0 MIF HLA-DRB1
73 lyme disease 10.0
74 sleep disorder 10.0
75 neuropathy 10.0
76 hashimoto thyroiditis 10.0
77 vitiligo-associated multiple autoimmune disease susceptibility 6 10.0
78 dermatitis, atopic 10.0
79 vitiligo-associated multiple autoimmune disease susceptibility 1 10.0
80 constipation 10.0
81 mastocytosis 10.0
82 thyroiditis 10.0
83 osteoarthritis 10.0
84 autoimmune disease 10.0
85 venous insufficiency 10.0
86 hypoparathyroidism 10.0
87 vestibular neuronitis 10.0
88 neuritis 10.0
89 neurilemmoma 10.0
90 alopecia 10.0
91 cerebrospinal fluid leak 10.0
92 perilymphatic fistula 10.0
93 sudden sensorineural hearing loss 10.0
94 rare surgical neurologic disease 10.0
95 bullous keratopathy 10.0 MIP AQP4 AQP3 AQP2 AQP1
96 idiopathic bronchiectasis 10.0 HLA-DRB1 HLA-C
97 rheumatoid arthritis, systemic juvenile 10.0 MIF HLA-DRB1
98 pityriasis rosea 9.9 HLA-DRB1 HLA-C
99 neuromyelitis optica 9.9 HLA-DRB1 AQP5 AQP4 AQP1
100 ocular cicatricial pemphigoid 9.9 MIF HLA-DRB1
101 spondyloarthropathy 1 9.9
102 facial spasm 9.9
103 glaucoma, primary open angle 9.9
104 keratitis, hereditary 9.9
105 motion sickness 9.9
106 polykaryocytosis inducer 9.9
107 scleroderma, familial progressive 9.9
108 retinitis pigmentosa 9.9
109 pituitary adenoma, prolactin-secreting 9.9
110 deafness, progressive, with stapes fixation 9.9
111 meningioma, radiation-induced 9.9
112 meningioma, familial 9.9
113 coronary heart disease 1 9.9
114 hyperprolactinemia 9.9
115 cogan syndrome 9.9
116 drug allergy 9.9
117 neuroretinitis 9.9
118 rickets 9.9
119 open-angle glaucoma 9.9
120 vertebral artery occlusion 9.9
121 spinal meningioma 9.9
122 inflammatory spondylopathy 9.9
123 viral labyrinthitis 9.9
124 uveitis 9.9
125 generalized anxiety disorder 9.9
126 rheumatic disease 9.9
127 factitious disorder 9.9
128 vascular disease 9.9
129 hyperinsulinism 9.9
130 enthesopathy 9.9
131 post-traumatic stress disorder 9.9
132 transient cerebral ischemia 9.9
133 ankylosis 9.9
134 retinal vascular disease 9.9
135 antiphospholipid syndrome 9.9
136 retinitis 9.9
137 milk allergy 9.9
138 secretory meningioma 9.9
139 lymphoplasmacyte-rich meningioma 9.9
140 intracranial hypotension 9.9
141 somatoform disorder 9.9
142 movement disease 9.9
143 neurotic disorder 9.9
144 middle ear disease 9.9
145 eye disease 9.9
146 acute stress disorder 9.9
147 spondylitis 9.9
148 peptic ulcer disease 9.9
149 osteochondrosis 9.9
150 ileus 9.9
151 measles 9.9
152 hypopituitarism 9.9
153 intracranial hypertension 9.9
154 interstitial keratitis 9.9
155 myotonic dystrophy 9.9
156 endolymphatic sac tumor 9.9
157 hyperacusis 9.9
158 autonomic dysfunction 9.9
159 cytomegalovirus infection 9.9
160 systemic autoimmune disease 9.9
161 spontaneous intracranial hypotension 9.9
162 pik3ca-related overgrowth syndrome 9.9
163 autosomal dominant non-syndromic sensorineural deafness type dfna 9.9
164 epilepsy 9.9
165 toxoplasmosis 9.9
166 ige responsiveness, atopic 9.9
167 ovarian cancer 9.9
168 primrose syndrome 9.9
169 deafness, autosomal dominant 6 9.9
170 prekallikrein deficiency 9.9
171 migraine with aura 9.9
172 glucose intolerance 9.9
173 depersonalization disorder 9.9
174 tympanosclerosis 9.9
175 guillain-barre syndrome 9.9
176 branch retinal artery occlusion 9.9
177 impotence 9.9
178 melanoma 9.9
179 arteriosclerosis 9.9
180 hemangioma 9.9
181 papillary serous adenocarcinoma 9.9
182 periarthritis 9.9
183 adenocarcinoma 9.9
184 food allergy 9.9
185 papillary adenocarcinoma 9.9
186 serous cystadenocarcinoma 9.9
187 lipid metabolism disorder 9.9
188 demyelinating disease 9.9
189 rhinitis 9.9
190 vasomotor rhinitis 9.9
191 agoraphobia 9.9
192 conjunctivitis 9.9
193 cerebrovascular disease 9.9
194 premenstrual tension 9.9
195 retinal artery occlusion 9.9
196 nervous system disease 9.9
197 herpes zoster oticus 9.9
198 epiglottitis 9.9
199 meningitis 9.9
200 cerebral arteriosclerosis 9.9
201 dysautonomia 9.9
202 virus-associated trichodysplasia spinulosa 9.9
203 overgrowth syndrome 9.9
204 oligoarticular juvenile idiopathic arthritis 9.9 PTPN22 MIF HLA-DRB1
205 vogt-koyanagi-harada disease 9.7 PTPN22 HLA-DRB1 HLA-C
206 impaired renal function disease 9.6 MIP AQP7 AQP6 AQP4 AQP3 AQP2
207 central nervous system vasculitis 9.6 PTPN22 HLA-DRB1
208 diabetes insipidus, nephrogenic, autosomal 9.4 MIP AQP7 AQP6 AQP5 AQP4 AQP3
209 behcet syndrome 9.2 TLR10 PTPN22 HLA-DRB1 HLA-C

Comorbidity relations with Meniere Disease via Phenotypic Disease Network (PDN): (showing 7, show less)


Active Vestibular Meniere's Disease Anxiety
Esophagitis Hypertension, Essential
Hypothyroidism Labyrinthitis
Transient Cerebral Ischemia

Graphical network of the top 20 diseases related to Meniere Disease:



Diseases related to Meniere Disease

Symptoms & Phenotypes for Meniere Disease

Human phenotypes related to Meniere Disease:

31 (showing 3, show less)
# Description HPO Frequency HPO Source Accession
1 hearing impairment 31 HP:0000365
2 vertigo 31 HP:0002321
3 tinnitus 31 HP:0000360

Symptoms via clinical synopsis from OMIM:

56
Head And Neck Ears:
tinnitus
vertigo, episodic
hearing impairment, sensorineural, fluctuating
aural fullness

Clinical features from OMIM:

156000

UMLS symptoms related to Meniere Disease:


vertigo, tinnitus, snoring, sore throat, coughing, vertigo/dizziness, equilibration disorder

GenomeRNAi Phenotypes related to Meniere Disease according to GeneCards Suite gene sharing:

26 (showing 7, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00221-A-1 10.07 PRKCB
2 Decreased viability GR00221-A-2 10.07 PRKCB
3 Decreased viability GR00221-A-4 10.07 PRKCB
4 Decreased viability GR00381-A-1 10.07 AQP1 DTNA
5 Decreased viability GR00381-A-3 10.07 DTNA
6 Decreased viability GR00402-S-2 10.07 AQP1 AQP2 AQP3 AQP4 AQP5 AQP6
7 no effect GR00402-S-1 9.62 AQP1 AQP2 AQP3 AQP4 AQP5 AQP6

MGI Mouse Phenotypes related to Meniere Disease:

45 (showing 2, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 hearing/vestibular/ear MP:0005377 9.5 AQP1 AQP3 AQP4 AQP5 COCH MIF
2 renal/urinary system MP:0005367 9.17 AQP1 AQP2 AQP3 AQP4 AQP6 AQP7

Drugs & Therapeutics for Meniere Disease

Drugs for Meniere Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 128, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sodium citrate Approved, Investigational Phase 4 68-04-2
2
Betahistine Approved, Investigational Phase 4 5638-76-6 2366
3
Tocopherol Approved, Investigational Phase 4 1406-66-2, 54-28-4 14986
4
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
5
Cisplatin Approved Phase 4 15663-27-1 84093 441203 2767
6
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
7
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
8
Azithromycin Approved Phase 4 83905-01-5 55185 447043
9
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
10
Folic acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
11
Vitamin E Approved, Nutraceutical, Vet_approved Phase 4 59-02-9 14985
12
Niacin Approved, Investigational, Nutraceutical Phase 4 59-67-6 938
13 Tocotrienol Investigational Phase 4 6829-55-6
14 Protective Agents Phase 4
15 Vasodilator Agents Phase 4
16 Citrate Phase 4
17 Sildenafil Citrate Phase 4 171599-83-0
18 Phosphodiesterase Inhibitors Phase 4
19 Phosphodiesterase 5 Inhibitors Phase 4
20 Vitamins Phase 4
21 Trace Elements Phase 4
22 Micronutrients Phase 4
23 Tocopherols Phase 4
24 Hypolipidemic Agents Phase 4
25 Vitamin B Complex Phase 4
26 Antioxidants Phase 4
27 Vitamin B3 Phase 4
28 Nutrients Phase 4
29 Tocotrienols Phase 4
30 Vitamin B9 Phase 4
31 Folate Phase 4
32 Lipid Regulating Agents Phase 4
33 Nicotinic Acids Phase 4
34 Antimetabolites Phase 4
35 Pharmaceutical Solutions Phase 4
36 Dexamethasone 21-phosphate Phase 4
37 Anesthetics Phase 4
38 Central Nervous System Depressants Phase 4
39 Hormones Phase 4
40 Anti-Bacterial Agents Phase 4
41 Antiemetics Phase 4
42 Gastrointestinal Agents Phase 4
43 Anti-Infective Agents Phase 4
44 Hormone Antagonists Phase 4
45 Autonomic Agents Phase 4
46 Anti-Inflammatory Agents Phase 4
47 Antineoplastic Agents, Hormonal Phase 4
48 glucocorticoids Phase 4
49 BB 1101 Phase 4
50 HIV Protease Inhibitors Phase 4
51
protease inhibitors Phase 4
52 Opiate Alkaloids Phase 4
53
Acyclovir Approved Phase 2, Phase 3 59277-89-3 2022
54
Lamotrigine Approved, Investigational Phase 3 84057-84-1 3878
55
Prednisolone Approved, Vet_approved Phase 2, Phase 3 50-24-8 5755
56
Methylprednisolone Approved, Vet_approved Phase 2, Phase 3 83-43-2 6741
57
Methylprednisolone hemisuccinate Approved Phase 2, Phase 3 2921-57-5
58
Prednisolone phosphate Approved, Vet_approved Phase 2, Phase 3 302-25-0
59 Prednisolone acetate Approved, Vet_approved Phase 2, Phase 3 52-21-1
60
Loperamide Approved Phase 3 53179-11-6 3955
61
Famciclovir Approved, Investigational Phase 3 104227-87-4 3324
62
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
63
Prednisolone hemisuccinate Experimental Phase 2, Phase 3 2920-86-7
64 Antipsychotic Agents Phase 3
65 Tranquilizing Agents Phase 3
66 Anticonvulsants Phase 3
67 Psychotropic Drugs Phase 3
68 Sodium Channel Blockers Phase 3
69 Calcium, Dietary Phase 3
70 calcium channel blockers Phase 3
71 Diuretics, Potassium Sparing Phase 3
72 Methylprednisolone Acetate Phase 2, Phase 3
73 Neuroprotective Agents Phase 2, Phase 3
74 Gentamicins Phase 2, Phase 3
75 Ginkgo Phase 3
76 Antidiarrheals Phase 3
77 Antisecretory factor Phase 3
78 Antiviral Agents Phase 3
79
Latanoprost Approved, Investigational Phase 2 130209-82-4 5282380 5311221
80
Selenium Approved, Investigational, Vet_approved Phase 1, Phase 2 7782-49-2
81
Ebselen Investigational Phase 2 60940-34-3 3194
82 Antihypertensive Agents Phase 2
83 Cyclooxygenase Inhibitors Phase 2
84 Anti-Inflammatory Agents, Non-Steroidal Phase 2
85 Anti-Ulcer Agents Phase 2
86 Analgesics, Non-Narcotic Phase 2
87 Antirheumatic Agents Phase 2
88 Antacids Phase 2
89 Interleukin 1 Receptor Antagonist Protein Phase 1, Phase 2
90
Phenol Approved, Experimental 108-95-2 996
91
Lorazepam Approved 846-49-1 3958
92
Ondansetron Approved 99614-02-5 4595
93
Meclizine Approved 569-65-3 4034
94
Diazepam Approved, Illicit, Investigational, Vet_approved 439-14-5 3016
95
Diphenhydramine Approved, Investigational 147-24-0, 58-73-1 3100
96
Promethazine Approved, Investigational 60-87-7 4927
97
Histamine Approved, Investigational 51-45-6 774
98
Morphine Approved, Investigational 57-27-2 5288826
99
Cyclizine Approved 82-92-8 6726
100 Kava Approved, Investigational, Nutraceutical 9000-38-8
101
Ginseng Approved, Investigational, Nutraceutical 50647-08-0
102 Anti-Anxiety Agents
103 Anesthetics, Local
104 GABA Agents
105 Hypnotics and Sedatives
106 Dermatologic Agents
107 Serotonin Agents
108 Antipruritics
109 Serotonin Antagonists
110 Anti-Allergic Agents
111 GABA Modulators
112 Hemostatics
113 Natriuretic Agents
114 Vasoconstrictor Agents
115 Arginine Vasopressin
116 Vasopressins
117 Coagulants
118 diuretics
119 Neurotransmitter Agents
120
Histamine Phosphate 51-74-1 65513
121 Analgesics
122 Angelica
123 Narcotics
124 Histamine Antagonists
125 Analgesics, Opioid
126 Histamine H1 Antagonists
127
Arginine Investigational, Nutraceutical 74-79-3 6322
128
Serotonin Investigational, Nutraceutical 50-67-9 5202

Interventional clinical trials:

(showing 57, show less)
# Name Status NCT ID Phase Drugs
1 A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study Of The Efficacy and Safety Of Sildenafil Given For The Acute Treatment Of Meniere's Disease Completed NCT00145483 Phase 4 Sildenafil
2 A Double-Blind, Placebo-Controlled, Randomized, Clinical Study of the Effects of Betaserc® 24 mg (1 Tablet b.i.d Over 3 Months) on Vestibular Compensation Following Vestibular Neurotomy in Patients With Disabling Menière's Disease Completed NCT00160238 Phase 4 Betahistine 24 mg bid (Betaserc)
3 Phase 3 Study of Efficacy of Local Overpressure Treatment for Meniere's Disease Completed NCT00831688 Phase 4
4 Effect of Stellate Ganglion Block on Meniere's Disease Completed NCT01574313 Phase 4 0.25mg, fludiazine;25mg cephadol@ (diphenidol);200mg kentons@ (tocopherol nicotinate).
5 A Multicenter, Randomized, Open-label Clinical Study With a Concurrent Control Group to Assess the Effectiveness and Safety of Combined Therapy With Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets for Patients With Meniere's Disease Completed NCT02718846 Phase 4 Meniace;Isobide
6 Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment. Completed NCT01372904 Phase 4 Dexamethasone Phosphate
7 Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease Recruiting NCT02530931 Phase 4 Gadolinium
8 Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS) Recruiting NCT02529475 Phase 4 Gadoteric acid
9 Effect of Adding Azithromycin to Dexamethasone in Preventing Post-operative Nausea and Vomiting in Caesarean Section Under Spinal Anesthesia With Spinal Opiate. Not yet recruiting NCT03165123 Phase 4 Oral Azithromycin tablet;Intravenous dexamethasone
10 Assessment of Acyclovir Efficacy Versus Placebo in Controlling Vertigo Attacks of Patients With Meniere's Disease Visited in Amiralam Hospital Unknown status NCT01729767 Phase 2, Phase 3 Acyclovir;Placebo
11 Antisecretory Factor (AF) Effects on Intraocular-pressure: a Placebo-controlled Randomised Study Unknown status NCT02731118 Phase 3
12 Lamotrigine for Ménière's Disease: a Double-blind, Placebo-controlled Pilot Study Completed NCT02158585 Phase 3 Lamotrigine;Placebo
13 Effectiveness of Transtympanic Steroids in Unilateral Ménière's Disease: a Randomised Controlled Double-Blind Trial Completed NCT00802529 Phase 2, Phase 3 Methylprednisolone;Gentamicin
14 A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease Completed NCT02612337 Phase 3 OTO-104;Placebo
15 A Random Controlled Clinical Trial:l Traditional Chinese Diaoshi Jifa Therapy of Meniere's Disease Completed NCT01454726 Phase 3
16 Conventional Versus Virtual Reality Based Vestibular Rehabilitation; Effect on Dizziness, Gait and Balance Completed NCT01442623 Phase 2, Phase 3
17 A Prospective, Randomized, Double Blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease Recruiting NCT03664674 Phase 3 OTO-104;Placebo
18 Salovum (Antisecretory Factor) in Patients With Severe Traumatic Brain Injury Recruiting NCT03339505 Phase 3
19 A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease Terminated NCT02717442 Phase 3 OTO-104;Placebo
20 A 6-Month, Multicenter, Phase 3, Open-Label Extension Safety Study of OTO-104 Given At 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease Terminated NCT02768662 Phase 3 OTO-104
21 A 6-Month, Multicenter, Phase 3, Open-Label Extension Safety Study of OTO-104 Given At 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease Terminated NCT02706730 Phase 3 OTO-104
22 Treatment of Hearing Fluctuation in Unilateral Meniere's Disease: A Randomized, Placebo-controlled Clinical Trial of Famciclovir Terminated NCT01526408 Phase 3 Famciclovir;Placebo
23 A Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Determine the Efficacy, the Duration of Action, and Safety of Latanoprost in Patients With Menière's Disease Unknown status NCT01973114 Phase 2 Latanoprost
24 A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 2b Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease Completed NCT01412177 Phase 2 OTO-104;Placebo
25 A 6-Month, Prospective, Randomized, Multicenter, Placebo-Controlled Safety Study of OTO-104 Given at 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease Followed by a 6-Month Open-Label Extension Completed NCT02265393 Phase 2 OTO-104;Placebo
26 A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Safety And Efficacy of SPI-1005 in Meniere's Disease Completed NCT03325790 Phase 2 200mg SPI-1005 BID;400mg SPI-1005 BID
27 Phase 1b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of SPI-1005 in Meniere's Disease Completed NCT02603081 Phase 1, Phase 2 SPI-1005
28 An Open-label Study of the Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease Completed NCT01950312 Phase 2 gevokizumab
29 A Phase I/II Open-label Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease Completed NCT01267994 Phase 1, Phase 2 Anakinra
30 The Attenuation of Second Generation Antipsychotic Induced Weight Gain in Adolescents and Adults Using Betahistine: A Double-Blind, Placebo-Controlled Trial Completed NCT00709202 Phase 2 Betahistine;Placebo Oral Tablet
31 A 1-Year, Phase 2, Open-Label Safety Study of OTO-104 Given at 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease Terminated NCT02740387 Phase 2 OTO-104
32 A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 1B Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease Completed NCT01084525 Phase 1 OTO-104 (steroid) 3 mg;Placebo;OTO-104 (steroid) 12 mg
33 Diagnostic Agreement of Electrophysiological Audiovestibular Examinations With Magnetic Resonance Imaging (MRI) of the Inner Ear in Revealing Endolymphatic Hydrops (EH) in Patients With Certain or Probable Meniere's Disease (MD) Unknown status NCT03215420
34 INTRATYMPANIC STEROID TREATMENT FOR THE PREVENTION OF INNER EAR TOXICITY ASSOCIATED WITH SYSTEMIC TREATMENT WITH CISPLATIN. Unknown status NCT01285674 Intra-tympanic Cisplatinum
35 Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent Completed NCT02080312 Magnevist (gadopentetate dimeglumine)
36 Vasopressin and V2 Receptor in Meniere's Disease Completed NCT00599560
37 Clinical Study of Endolymphatic Sac Drainage With or Without Steroids for Intractable Meniere's Disease Completed NCT00500474
38 Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach Completed NCT02309099
39 Post-marketing Observational Program of Betaserc® (Betahistine Dihydrochloride) to Evaluate Effectiveness in Patients With Vestibular Vertigo in Routine Practice Completed NCT01759251
40 Effect of Preoperative Oral Carbohydrate Loading on Recovery in Patients Undergoing Day-case Cholecystectomy. A Randomised Controlled Trial. Completed NCT03757208
41 Effects of Kinesio Taping in Patients With Somatosensory Tinnitus: A Randomized Controlled Trial Completed NCT03782220
42 A Randomized Trial to Evaluate Resolution of Symptoms Using Vestibular Rehab Versus Conventional Therapy in Patients Presenting to the Emergency Department (ED) With Diagnosis of Benign Paroxysmal Positional Vertigo (BPPV) Completed NCT00641797 Meclizine;Lorazepam;Diphenhydramine;Ondansetron
43 Reduction of Plasma Vasopressin Level in Patients With Meniere's Disease Recruiting NCT01099046
44 Cochlear Implantation During Vestibular Schwannoma Removal or During Labyrinthectomy Surgery for Treatment of Meniere's Disease Recruiting NCT03795675
45 Production of a Device to Obtain Continuous Ambulatory Vestibular Assessment (CAVA) - Dizziness Trial Recruiting NCT04026516
46 Consequence of Unilateral Vestibular Loss on Visual Abilities Recruiting NCT03581331
47 Saccular Dilatation, Endolymphatic Hydrops and Vestibular Schwannoma : is Vertigo Really Correlated to the Tumor ? A Retrospective Study Based on FIESTA-C Sequence Using a 3 Tesla MRI Recruiting NCT03593577
48 Transcranial Vibrating System for Improving Outcomes of Vestibular Physical Therapy Recruiting NCT03795168
49 Non-inferiority of Virtual Reality Compared to Other Forms of Optokinetic Stimulation in the Rehabilitation of Vestibular Syndromes. Randomized Controlled Trial. Recruiting NCT03838562
50 Cochlear Implantation for Treatment of Single-sided Deafness Active, not recruiting NCT02532972
51 A Prospective, Randomized, Blinded, Placebo-controlled, Single Center, Efficacy Study of a Mastoid Device in Subjects With Ménière's Disease Enrolling by invitation NCT03520322
52 Safety, Effectiveness, and Cost-effectiveness of an Herbal Medicine, Gongjin-dan, in Subjects With Chronic Dizziness: a Prospective, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group, Clinical Trial Not yet recruiting NCT03219515 Gongjin-Dan;Placebo
53 Variability and Specificity in Reactive Stabilization Movements to Diverse Slip Perturbations Not yet recruiting NCT03755336 Early Phase 1
54 Visual and Vestibular Percepts of Motion Not yet recruiting NCT04142697
55 Comparison Between Cyclizine and Dexamethasone for Prevention of Nausea and Vomiting After Intrathecal Morphine in Patients Undergoing Cesarean Section Not yet recruiting NCT03931135 IV Cyclizine versus IV Dexamethasone for prevention of nausea and vomiting after intrathecal morphine in patients undergoing cesarean section
56 Effects of Infrasound Exposure on Measures of Endolymphatic Hydrops Terminated NCT03132961
57 Diagnosing Endolymphatic Hydrops in Patients With Meniere Disease Using Magnetic Resonance Imaging With Intravenous Gadolinium Administration Withdrawn NCT02371798 Gadopentetate dimeglumine

Search NIH Clinical Center for Meniere Disease

Cochrane evidence based reviews: meniere disease

Genetic Tests for Meniere Disease

Anatomical Context for Meniere Disease

MalaCards organs/tissues related to Meniere Disease:

40
Testes, Bone, Brain, Eye, Heart, T Cells, Thyroid

Publications for Meniere Disease

Articles related to Meniere Disease:

(showing 2441, show less)
# Title Authors PMID Year
1
Absence of COCH mutations in patients with Meniere disease. 54 61 56
14704763 2004
2
A novel missense variant in PRKCB segregates low-frequency hearing loss in an autosomal dominant family with Meniere's disease. 61 56
27329761 2016
3
Identification of two novel mutations in FAM136A and DTNA genes in autosomal-dominant familial Meniere's disease. 61 56
25305078 2015
4
Familial clustering and genetic heterogeneity in Meniere's disease. 61 56
23521103 2014
5
Meniere's disease. 61 56
18675691 2008
6
The cause (multifactorial inheritance) and pathogenesis (endolymphatic malabsorption) of Meniere's disease and its symptoms (mechanical and chemical). 61 56
4013733 1985
7
Otopetrin-2 Immunolocalization in the Human Macula Utricle. 61 42
31092032 2019
8
Anticipation in Menière's disease. 56
7642988 1995
9
Occurrence of episodic vertigo and hearing loss in families. 56
5892598 1965
10
Menière's disease treated by grommet insertion. 42
31508988 2019
11
Aural fullness and transtympanic ventilation tubes in Ménière's disease: a scoping review. 42
31172892 2019
12
Aquaporins as potential drug targets for Meniere's disease and its related diseases. 54 61
19096777 2009
13
Aquaporins and Meniere's disease. 54 61
16974147 2006
14
Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease. 54 61
11889388 2002
15
Anti-heat shock protein 70 antibodies in Meniere's disease. 54 61
11224793 2001
16
Proteomics and the inner ear. 54 61
11790893 2001
17
Anti-heat shock protein 70 antibodies in Meniere's disease. 54 61
10983953 2000
18
Recognition of a dominant epitope in bovine heat-shock protein 70 in inner ear disease. 54 61
10201752 1999
19
Failure of elevated heat shock protein 70 antibodies to alter cochlear function in mice. 54 61
9508029 1998
20
Comparison of anti-heat shock protein 70 (anti-hsp70) and anti-68-kDa inner ear protein in the sera of patients with Meniere's disease. 54 61
9023247 1997
21
A possible mechanism of the formation of endolymphatic hydrops and its associated inner ear disorders. 61
31623941 2020
22
Impact of Underlying Diagnosis on Speech and Quality of Life Outcomes After Cochlear Implantation for Single-Sided Deafness. 61
32032297 2020
23
Effects of endolymphatic sac decompression combined with posterior tympanotomy with local steroids for intractable Meniere's disease. 61
32031482 2020
24
Enrichment of damaging missense variants in genes related with axonal guidance signalling in sporadic Meniere's disease. 61
31494579 2020
25
CT imaging of the Eustachian tube using focal contrast medium administration: a feasibility study in humans. 61
32030198 2020
26
Evolution of vestibular disorders in older adults: From young-old to middle-old to oldest-old. 61
31742857 2020
27
Bilateral Vestibular Dysfunction. 61
31935769 2020
28
Letter to Editor concerning the "Therapeutic strategies in the treatment of Meniere's disease: the Italian Experience". 61
31912215 2020
29
Food-induced stimulation of the antisecretory factor to improve symptoms in Meniere's disease: our results. 61
31605188 2020
30
A hypothetical proposal for association between migraine and Meniere's disease. 61
31629154 2020
31
Change of VOR gain and pure-tone threshold after single low-dose intratympanic gentamicin injection in Meniere's disease. 61
31909683 2020
32
A model of viscoelastoplasticity in the cochleo-saccular membranes. 61
31890885 2019
33
Clinical long-term effects of surgical treatment for intractable Meniere's disease: a more than 13-year follow-up after pressure treatment and further surgical treatment for intractable vertigo. 61
31556757 2019
34
Cross-Sectional Analysis of Cognitive Dysfunction in Patients With Vestibular Disorders. 61
31842021 2019
35
Clinical features and outcomes of benign recurrent vertigo: A longitudinal study. 61
31883379 2019
36
Revision surgery after triple semicircular canal plugging and morphologic changes of vestibular organ. 61
31852932 2019
37
Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities. 61
30987439 2019
38
Magnetic resonance imaging of the endolymphatic space in patients with acute low-tone sensorineural hearing loss. 61
31076273 2019
39
Letter to the editors: comment on "Dissociation of caloric and head impulse tests: a marker of Meniere's disease". 61
31571004 2019
40
Pharmacologic and surgical therapies for patients with Meniere's disease: a protocol for a systematic review and meta-analysis. 61
31888735 2019
41
Endolymphatic volume in patients with meniere's disease and healthy controls: Three-dimensional analysis with magnetic resonance imaging. 61
31890884 2019
42
Nutritional Mushroom Treatment in Meniere's Disease with Coriolus versicolor: A Rationale for Therapeutic Intervention in Neuroinflammation and Antineurodegeneration. 61
31906226 2019
43
Genetic architecture of Meniere's disease. 61
31874721 2019
44
A comparison of endolymphatic shunt surgery and intratympanic gentamicin for meniere's disease. 61
31808957 2019
45
Hearing Preservation and Speech Outcomes After Cochlear Implantation in Meniere's Disease. 61
31821566 2019
46
Current Understanding and Clinical Management of Meniere's Disease: A Systematic Review. 61
31887752 2019
47
Head-Shaking Nystagmus in the Early Stage of Unilateral Meniere's Disease. 61
31846924 2019
48
"Reversed polarization" of Na/K-ATPase-a sign of inverted transport in the human endolymphatic sac: a super-resolution structured illumination microscopy (SR-SIM) study. 61
31713726 2019
49
A Trigeminal Schwannoma Masked by Solely Vestibulocochlear Symptoms. 61
31758677 2019
50
Immunolocalization of calcium sensing and transport proteins in the murine endolymphatic sac indicates calciostatic functions within the inner ear. 61
31338584 2019
51
Are Meniere's disease patients with otolith organ impairment more likely to have balance dysfunction? 61
31536431 2019
52
Diagnostic assessment of patients with Meniere's disease through caloric testing and the video-head-impulse test. 61
31870737 2019
53
Long Term Outcomes of Intratympanic Dexamethasone in Intractable Unilateral Meniere's Disease. 61
31750179 2019
54
Simultaneous Presentation of Benign Paroxysmal Positional Vertigo and Meniere's Disease - Case Report. 61
32010389 2019
55
Could there be any merit in lumping primary open-angle glaucoma, idiopathic intracranial hypertension and Meniere's disease into a novel and discrete category of fluid tension disorders? 61
31437670 2019
56
A tinnitus symphony in 100 patients with Meniere's disease. 61
31560819 2019
57
Molecular genetic studies of familial Meniere's disease. 61
30904974 2019
58
Solute carrier family 4 member 1 might participate in the pathogenesis of Meniere's disease in a murine endolymphatic hydrop model. 61
31536436 2019
59
Low-dose intratympanic gentamicin administration for unilateral Meniere's disease using a method based on clinical symptomatology: Preliminary results. 61
31537428 2019
60
Expression of aquaporins in inner ear disease. 61
31593306 2019
61
Recovery of ocular and cervical vestibular evoked myogenic potentials after treatment of inner ear diseases. 61
31070081 2019
62
[Vertigo, a Driver's Licence with and without Permission to Drive: Are the Current Guidelines Justified?] 61
31610595 2019
63
Role of Cervical Vestibular Evoked Myogenic Potentials (cVEMP) as Outcome-Measure of Glycerol Test. 61
31741998 2019
64
Are diuretics useful in the treatment of meniere disease? 61
31046134 2019
65
Cervical VEMP tuning changes by Meniere's disease stages. 61
31637299 2019
66
Quantitative analysis of cochlear signal intensity on three-dimensional and contrast-enhanced fluid-attenuated inversion recovery images in patients with Meniere's disease: Correlation with the pure tone audiometry test. 61
30953681 2019
67
Peripheral and central vestibular system findings in Meniere's disease. 61
32009345 2019
68
Evolution of Meniere's Disease from MD 1.0, via MD 1.5, to MD 2.0. 61
31271345 2019
69
Prediction of Unilateral Meniere's Disease Attack Using Inner Ear Test Battery. 61
31567497 2019
70
Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease. 61
31262549 2019
71
Late-onset Cogan's syndrome associated with large-vessel vasculitis. 61
28583785 2019
72
Can verapamil be effective in controlling vertigo and headache attacks in vestibular migraine accompanied with Meniere's disease? A preliminary study. 61
30989371 2019
73
Effect of pre-operative oral carbohydrate loading on recovery after day-case cholecystectomy: A randomised controlled trial. 61
31021880 2019
74
Comprehensive comparison of MR image quality between intratympanic and intravenous gadolinium injection using 3D real IR sequences. 61
31130050 2019
75
[Evaluation of vestibular evoked myogenic potential, caloric test and cochlear electrogram in the diagnosis of Meniere's disease]. 61
31446722 2019
76
Magnetic resonance-based volumetric measurement of the endolymphatic space in patients with Meniere's disease and other endolymphatic hydrops-related diseases. 61
30503567 2019
77
Benign paroxysmal positional vertigo in Meniere's disease: systematic review and meta-analysis of frequency and clinical characteristics. 61
31410549 2019
78
The natural progression of low-frequency hearing loss in patients who meet hybrid implant system candidacy criteria. 61
31393603 2019
79
Direction-Changing and Direction-Fixed Positional Nystagmus in Patients With Vestibular Neuritis and Meniere Disease. 61
30509014 2019
80
Tone burst electrocochleography disproves a diagnosis of Meniere's disease treated aggressively. 61
31428809 2019
81
Therapeutic Effect of Intratympanic Injection of Dexamethasone plus Hyaluronic Acid on Patients with Meniere's disease. 61
31384587 2019
82
3D-real IR MRI of Meniere's disease with partial endolymphatic hydrops. 61
31113683 2019
83
Vertical head impulse and caloric are complementary but react opposite to Meniere's disease hydrops. 61
30515842 2019
84
Amiodarone-Induced Syndrome of Inappropriate Antidiuretic Hormone: A Case Report and Review of the Literature. 61
31258313 2019
85
Volume-rendered computed tomography images of the surgical field for endolymphatic sac surgery. 61
30929055 2019
86
Migraine increases the proportion of sudden sensorineural hearing loss: A longitudinal follow-up study. 61
30389313 2019
87
Autoinflammatory characteristics and short-term effects of delivering high-dose steroids to the surface of the intact endolymphatic sac and incus in refractory Ménière's disease. 61
31223300 2019
88
[Vertigo in children:composition and clinical characteristics]. 61
31163516 2019
89
[The prognostic value of glycerol test of electrocochleography on the effects of endolymphatic sac decompression surgery in patients with unilateral Meniere's disease]. 61
31163517 2019
90
Office-Based Otology Procedures. 61
30905565 2019
91
Complete Recovery Following Electroacupuncture Therapy in Refractory Unilateral Sensorineural Hearing Loss. 61
31034901 2019
92
Vestibular Migraine: How to Sort it Out and What to Do About it. 61
31094996 2019
93
A plea for systematic literature analysis and conclusive study design, comment on: "Systematic review of magnetic resonance imaging for diagnosis of Meniere disease". 61
31658075 2019
94
Dissociation of caloric and head impulse tests: a marker of Meniere's disease. 61
31222419 2019
95
[The effect of surgical treatment on Meniere's disease]. 61
31163521 2019
96
[Interpretation of international consensus on treatment of Meniere's disease]. 61
31163525 2019
97
Development and Preliminary Findings of the Dizziness Symptom Profile. 61
29979254 2019
98
Successful treatment of a child with definite Meniere's disease with the migraine regimen. 61
30803806 2019
99
Histamine H4 receptor gene polymorphisms: a potential contributor to Meniere disease. 61
31133025 2019
100
Clinical Characteristics of Bilateral Meniere's Disease in a Single Asian Ethnic Group. 61
30284277 2019
101
The Clinical Benefit of Device Therapy for Meniere's Disease in Adults: Systematic Review and Meta-Analysis. 61
31058601 2019
102
The Polymorphic Analysis of the Human Potassium Channel KCNE Gene Family in Meniere's Disease-A Preliminary Study. 61
31058602 2019
103
Quantitative evaluation of endolymphatic hydrops with MRI through intravenous gadolinium administration and VEMP in unilateral definite Meniere's disease. 61
30694377 2019
104
High parathyroid hormone levels are associated with poor balance in older persons: A cross-sectional study. 61
30704566 2019
105
[Analysis of clinical features of secondary benign paroxysmal positional vertigo]. 61
30813689 2019
106
[The critical thoughts on clinical diagnosis and treatment of Meniere's disease]. 61
30813682 2019
107
[Acoustic absorbance characteristics of wideband tympanometry in patients with Meniere's disease]. 61
30813690 2019
108
[Caloric test and hearing characteristics in patients with vestibular migraine and Meniere's disease]. 61
30813691 2019
109
Clinical features and management of Meniere's disease patients with drop attacks. 61
30604056 2019
110
Serum sickness disease in a patient with alopecia areata and Meniere' disease after PRP procedure. 61
30511475 2019
111
Symptoms in cervical vertigo. 61
30828627 2019
112
The pattern of hearing outcome following surgery of the semicircular canals. 61
30828630 2019
113
[Clinical diagnosis and surgical management of 110 cases of facial nerve schwannomas]. 61
30776861 2019
114
Neurologic Conditions: Dizziness and Vertigo. 61
30747510 2019
115
Tenotomy of the middle ear muscles : An unknown surgical approach in Meniere's disease. 61
30421285 2019
116
Inner ear pathologies impair sodium-regulated ion transport in Meniere's disease. 61
30390121 2019
117
Postoperative compensation after neurotomy in Meniere's disease: Retrospective study of 15 cases. 61
30658837 2019
118
Proteome of normal human perilymph and perilymph from people with disabling vertigo. 61
31185063 2019
119
Imaging of Temporal Bone. 61
30947168 2019
120
Peripheral Vestibular Disorders: An Epidemiologic Survey in 70 Million Individuals. 61
30289843 2019
121
Underappreciated Roles of the Translocase of the Outer and Inner Mitochondrial Membrane Protein Complexes in Human Disease. 61
30481057 2019
122
Demographic data and seasonal variation in peripheral vestibular disorders in ENT practices in Germany. 61
31256098 2019
123
Intralabyrinthine Schwannoma: Distinct Features for Differential Diagnosis. 61
31396141 2019
124
Are viral-infections associated with Ménière's Disease? A systematic review and meta-analysis of molecular-markers of viral-infection in case-controlled observational studies of MD. 61
31756230 2019
125
Predicting cochlear dead regions in patients with hearing loss through a machine learning-based approach: A preliminary study. 61
31158267 2019
126
[A role of vascular risk factors in the development of peripheral vestibulopathy]. 61
31825395 2019
127
Long-term outcomes of triple semicircular canal plugging for the treatment of intractable Meniere's disease: A single center experience of 361 cases. 61
31640108 2019
128
Three-Dimensional Magnetic Resonance Imaging Reveals the Relationship Between the Control of Vertigo and Decreases in Endolymphatic Hydrops After Endolymphatic Sac Drainage With Steroids for Meniere's Disease. 61
30778329 2019
129
A Case of Binocular Vertical Diplopia after Intratympanic Gentamicin Therapy. 61
31508383 2019
130
Endotype-Phenotype Patterns in Meniere's Disease Based on Gadolinium-Enhanced MRI of the Vestibular Aqueduct. 61
31024416 2019
131
Investigations of the Microvasculature of the Human Macula Utricle in Meniere's Disease. 61
31636542 2019
132
Correlation between auditory-vestibular functions and estrogen levels in postmenopausal patients with Meniere's disease. 61
30030864 2019
133
Subcellular Abnormalities of Vestibular Nerve Morphology in Patients With Intractable Meniere's Disease. 61
31555202 2019
134
Rare Variants of Putative Candidate Genes Associated With Sporadic Meniere's Disease in East Asian Population. 61
32038468 2019
135
Relationship Between Audio-Vestibular Functional Tests and Inner Ear MRI in Meniere's Disease. 61
29698363 2019
136
Excess of Rare Missense Variants in Hearing Loss Genes in Sporadic Meniere Disease. 61
30828346 2019
137
Systematic review of magnetic resonance imaging for diagnosis of Meniere disease. 61
31356219 2019
138
Differential Proinflammatory Signature in Vestibular Migraine and Meniere Disease. 61
31214186 2019
139
[Vascular mechanisms in Meniere's disease]. 61
31198220 2019
140
Comparison of acute vertigo diagnosis and treatment practices between otolaryngologists and non-otolaryngologists: A multicenter scenario-based survey. 61
30845218 2019
141
Meniere's Disease. 61
30947172 2019
142
Inter-frequency amplitude ratio of oVEMP for differentiating Meniere's disease from BPPV: clinical validation using a double-blind approach. 61
30382796 2019
143
Gadolinium-enhanced MRI reveals dynamic development of endolymphatic hydrops in Ménière's disease. 61
30600169 2018
144
[Optimization of delivering minimum Gd-DTPA at the posterior upper point on tympanic medial wall and hT2W-3D-FLAIR sequence for detecting endolymphatic hydrops]. 61
30585006 2018
145
Response of the inner ear to lipopolysaccharide introduced directly into scala media. 61
30366193 2018
146
Hyperglycemia and diabetes mellitus are related to vestibular organs dysfunction: truth or suggestion? A literature review. 61
29936650 2018
147
[Recent immunology research of Meniere's disease]. 61
30585012 2018
148
Evaluating Quality of Life in Patients With Meniere's Disease Treated as Migraine. 61
30198300 2018
149
[Study on the shift of ocular vestibular evoked myogenic potentials frequency tuning of Meniere's disease]. 61
30585001 2018
150
Does Schizoaffective Disorder explain the mental illnesses of Robert Schumann and Vincent Van Gogh? 61
30439846 2018
151
Transcanal endoscopic infracochlear vestibular neurectomy: A pilot cadaveric study. 61
30104073 2018
152
Diagnostic yield of MRI of the brain and IAC in patients with neurotologic complaints. 61
30055796 2018
153
Lermoyez syndrome revisited: 100-year mystery. 61
30776263 2018
154
[The downbeat nystagmus in 2 cases with unilateral Meniere's disease]. 61
30716811 2018
155
The vestibular aqueduct sign: Magnetic resonance imaging can detect abnormalities in both ears of patients with unilateral Meniere's disease. 61
30423380 2018
156
Instrumental head impulse test changes after intratympanic gentamicin for unilateral definite Ménière's disease: A systematic review and meta-analysis. 61
29402608 2018
157
Genetic contribution to vestibular diseases. 61
29582143 2018
158
Association of Meniere's disease and retinal vascular calibre: a prospective observational study in China. 61
30282681 2018
159
[The correlation between the hearing frequency and staging of Meniere's disease]. 61
30347538 2018
160
[Acupuncture combined with oral western medication for Meniere's disease: a randomized controlled trial]. 61
30672233 2018
161
Patient, disease, and outcome characteristics of benign paroxysmal positional vertigo with and without Meniere's disease. 61
30016894 2018
162
Role of Electronystagmography in Diagnosis of Secondary BPPV in Elderly Patients with Vertigo: A Retrospective Study. 61
30211103 2018
163
Gene Delivery into the Inner Ear and Its Clinical Implications for Hearing and Balance. 61
30274337 2018
164
[Risk factors for recurrence of benign paroxysmal positional vertigo: a Meta analysis]. 61
30282182 2018
165
Cochlear-Internal Canal and Cochlear-Facial Dehiscence: A Novel Entity. 61
30256207 2018
166
Subacute carbon monoxide poisoning presenting as vertigo and fluctuating low frequency hearing loss. 61
30094001 2018
167
Choristoma: Cervical Chondrocutaneous Branchial Remnants. 61
30345205 2018
168
The Reliability and Validity of "Dokuz Eylül University Meniere's Disease Disability Scale". 61
29283101 2018
169
European Position Statement on Diagnosis, and Treatment of Meniere's Disease. 61
30256205 2018
170
[Advances in peripheral vestibular diseases with downbeat nystagmus]. 61
29986573 2018
171
Vitamin D supplementation may improve symptoms in Meniere's disease. 61
29857909 2018
172
In vivo imaging of saccular hydrops in humans reflects sensorineural hearing loss rather than Meniere's disease symptoms. 61
29564597 2018
173
Histopathology of tympanic membranes from patients with ventilation tubes. 61
28774486 2018
174
Simultaneous labyrinthectomy and cochlear implantation in unilateral meniere's disease. 61
30062139 2018
175
Evidence of surgical treatments for intractable Meniere's disease. 61
28760332 2018
176
The theory of autoimmunity in Meniere's disease is lacking evidence. 61
28784462 2018
177
Analysis of non-posterior canal benign paroxysmal positional vertigo in patients treated using the particle repositioning chair: A large, single-institution series. 61
29544670 2018
178
Forkhead box C1 gene variant causing glaucoma and small vessel angiopathy can mimic multiple sclerosis. 61
29751260 2018
179
Effects of combined oral contraception containing drospirenone on premenstrual exacerbation of Meniere's disease: Preliminary study. 61
29573626 2018
180
Comparison of enhancement of the vestibular perilymph between gadoterate meglumine and gadobutrol at 3-Tesla in Meniere's disease. 61
29398574 2018
181
Newly Diagnosed Meniere's Disease: Clinical Course With Initiation of Noninvasive Treatment Including an Accounting of Vestibular Migraine. 61
29546771 2018
182
[Isolated vertigo as the first symptom of posterior circulation infarction:reporot of 11 cases]. 61
29798090 2018
183
[Clinical features and imaging characteristics of Meniere's disease verified by intravenous gadolinium contrast-enhanced magnetic resonance imaging]. 61
29747307 2018
184
Vestibulo-Cochlear Function After Cochlear Implantation in Patients With Meniere's Disease. 61
29764776 2018
185
Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease. 61
29654306 2018
186
Characterizing the Age and Stimulus Frequency Interaction for Ocular Vestibular-Evoked Myogenic Potentials. 61
28832351 2018
187
[Recurrent low frequency sensorineural deafness]. 61
29737749 2018
188
Thomsen J et al. - The non-specific effect of endolymphatic sac surgery in treatment of Meniere's disease: A prospective, randomized controlled study comparing "classic" endolymphatic sac surgery with the insertion of a ventilating tube in tympanic membrane. Acta Oto-Laryngol 1998: 118: 769-773. 61
29532729 2018
189
Genetics of vestibular syndromes. 61
29095749 2018
190
Pediatric Meniere's disease. 61
29447806 2018
191
The clinical characteristics and audiogram in 103 Meniere's disease patients with and without vestibular migraine. 61
28742261 2018
192
Intratympanal gentamicin in Meniere's disease: Effects on individual semicircular canals. 61
28292626 2018
193
[Non-drug therapy of vertigo]. 61
30251976 2018
194
[The history of organization of the research laboratories based at the Department of Otorhinolaryngology of the Faculty of General Medicine]. 61
29488489 2018
195
Translabyrinthine approach to internal auditory meatus: A retrospective study. 61
29386735 2018
196
The Contributions of Vestibular Evoked Myogenic Potentials and Acoustic Vestibular Stimulation to Our Understanding of the Vestibular System. 61
30013504 2018
197
Vertigo Induced During Coitus. 61
30687228 2018
198
Increased prevalence and risk of anxiety disorders in adults with tinnitus: A population-based study in Taiwan. 61
29190572 2018
199
Steroid intracochlear distribution differs by administration method: Systemic versus intratympanic injection. 61
28304075 2018
200
Diagnosis of Vertigo and Dizziness Syndromes in a Neurological Outpatient Clinic. 61
29794430 2018
201
Measurements of Trunk Sway for Stance and Gait Tasks 2 Years after Vestibular Neurectomy. 61
30541000 2018
202
Clinical Characteristics and Etiology of Bilateral Vestibular Loss in a Cohort from Central Illinois. 61
29545765 2018
203
Benign paroxysmal positional vertigo associated with Meniere's disease. 61
30149485 2018
204
A Case of Medullary Infarction Presented Initial Symptoms Similar to Meniere's Disease. 61
29036757 2018
205
Oxidative Stress in the Blood Labyrinthine Barrier in the Macula Utricle of Meniere's Disease Patients. 61
30233382 2018
206
The Follow-Up Role of the Vestibular Evoked Myogenic Potential Test in Meniere's Disease. 61
29436794 2018
207
[The peculiar features of vestibular function disorders associated with Meniere's disease]. 61
29488491 2018
208
[The peculiar features of the clinical course of Meniere's disease associated with benign paroxysmal positional vertigo]. 61
29488493 2018
209
[Long-term results of endolymphatic sac mastoid drainage for Ménière disease]. 61
29757563 2018
210
Concomitant diseases and their effect on disease prognosis in Meniere's disease: diabetes mellitus identified as a negative prognostic factor. 61
28914106 2018
211
Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment. 61
30356417 2018
212
Recent and Frequent Vertigo Attacks Produce Negative Findings on Furosemide-Loading Vestibular Evoked Myogenic Potential Testing in Meniere's Disease. 61
30123180 2018
213
[The effectiveness of the intra-tympanic administration of methylprednisolone and gentamycin for the treatment of Meniere's disease]. 61
30412169 2018
214
Migraine Related Vertigo. 61
29238692 2017
215
The Etiological Relationship Between Migraine and Sudden Hearing Loss. 61
29076927 2017
216
Revision of a furosemide-loading vestibular-evoked myogenic potential protocol for detecting endolymphatic hydrops. 61
28749204 2017
217
Dizziness Symptom Type Prevalence and Overlap: A US Nationally Representative Survey. 61
28739195 2017
218
[Advance in research of delayed endolymphatic hydrops]. 61
29798406 2017
219
Cervical vestibular evoked myogenic potential tuning properties of patients with recurrent peripheral vestibulopathy: Is it Meniere's disease without hearing loss? 61
29102873 2017
220
Extended phenotype and clinical subgroups in unilateral Meniere disease: A cross-sectional study with cluster analysis. 61
28166395 2017
221
Longitudinal up-regulation of endolymphatic hydrops in patients with Meniere's disease during medical treatment. 61
29299506 2017
222
Comparative study between the caloric vestibular and the video-head impulse tests in unilateral Menière's disease. 61
28741403 2017
223
Methylprednisolone versus Dexamethasone for Control of Vertigo in Patients with Definite Meniere's disease. 61
29383315 2017
224
ELHnet: a convolutional neural network for classifying cochlear endolymphatic hydrops imaged with optical coherence tomography. 61
29082086 2017
225
Skew Deviation and Partial Ocular Tilt Reaction Due to Intratympanic Gentamicin Injection, with Review of the Literature. 61
29339961 2017
226
[The features of c/oVEMP in patient with unilateral Meniere's disease]. 61
29798104 2017
227
Endolymphatic hydrops imaging: Differential diagnosis in patients with Meniere disease symptoms. 61
28645678 2017
228
The Differential Diagnosis of Vertigo in Children: A Systematic Review of 2726 Cases. 61
29095392 2017
229
Current Treatment Options: Vestibular Migraine. 61
28965306 2017
230
NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy. 61
28847925 2017
231
Ictal downbeat nystagmus in bilateral Meniere's disease. 61
28821951 2017
232
Meniere's Disease and Vestibular Migraine: Updates and Review of the Literature. 61
28811849 2017
233
Degeneration of the vestibular nerve in unilateral Meniere's disease evaluated by galvanic vestibular-evoked myogenic potentials. 61
28719825 2017
234
MRI of endolymphatic hydrops in patients with Meniere's disease: a case-controlled study with a simplified classification based on saccular morphology. 61
27999985 2017
235
Selective Window Application of Gentamicin+ Dexamethasone in Meniere's Disease. 61
28716762 2017
236
Effects of Selective Seratonine Re-Uptake Inhibitors on Meniere's Disease. 61
28639557 2017
237
The Effectiveness of Vestibular Rehabilitation Interventions in Treating Unilateral Peripheral Vestibular Disorders: A Systematic Review. 61
26111348 2017
238
Detection of endolymphatic hydrops using traditional MR imaging sequences. 61
28413076 2017
239
Navigating the challenges of Meniere disease. 61
28594693 2017
240
Is Electrocochleography Still Helpful in Early Diagnosis of Meniere Disease? 61
28704892 2017
241
How minimally invasive vestibular neurotomy for incapacitating Meniere's disease improves dizziness and anxiety. 61
28125309 2017
242
Short Term Results of Intra Tympanic Gentamicin and Dexamethasone on Hearing and Tinnitus in Meniere's disease: A Case Control Study. 61
28723597 2017
243
Association between ambient particulate matter and disorders of vestibular function. 61
28236785 2017
244
Complete and irreversible unilateral vestibular loss: A novel rat model of vestibular pathology. 61
28390798 2017
245
A pipeline combining multiple strategies for prioritizing heterozygous variants for the identification of candidate genes in exome datasets. 61
28532469 2017
246
Hearing loss in Meniere's disease. 61
28162795 2017
247
Intratympanic Injection of Dexamethasone and Electrocochleographic Data in Cases of Definite One Sided Refractory Meniere's Disease. 61
28589104 2017
248
Long-term outcomes of endolymphatic sac shunting with local steroids for Meniere's disease. 61
28214024 2017
249
[The correlation analysis of the cochlear hydrops degree found by MRI angiography with Meiniere's disease classification]. 61
29871329 2017
250
"Canalolabyrinthine Schwannoma," A Rare Variant of Intralabyrinthine Schwannoma: A Case Report. 61
28085001 2017
251
[Etiological analysis on patients in department of vertigo and dizziness oriented outpatient]. 61
28395427 2017
252
Co-existence of Benign Paroxysmal Positional Vertigo and Meniere's Syndrome. 61
28085000 2017
253
Indispensable Role of Ion Channels and Transporters in the Auditory System. 61
27704564 2017
254
Ion transport its regulation in the endolymphatic sac: suggestions for clinical aspects of Meniere's disease. 61
27804084 2017
255
Bilateral Endolymphatic Hydrops in a Patient With Migraine Variant Without Vertigo: A Case Report. 61
27910089 2017
256
Diagnosis of endolymphatic hydrops by means of 3T magnetic resonance imaging after intratympanic administration of gadolinium. 61
28017456 2017
257
Is gentamycin delivery via sustained-release vehicles a safe and effective treatment for refractory Meniere's disease? A critical analysis of published interventional studies. 61
27623821 2017
258
Electrocochleographic recording in Asian adults: Preliminary normative data and demographic analyses. 61
29937834 2017
259
Comparison of caloric and head-impulse tests during the attacks of Meniere's disease. 61
27311766 2017
260
The blood labyrinthine barrier in the human normal and Meniere's disease macula utricle. 61
28325925 2017
261
[Guideline of diagnosis and treatment of Meniere disease (2017)]. 61
28395486 2017
262
[Advances in auditory function research of Meniere disease]. 61
28395500 2017
263
[Frequency characteristics of the semicicular canals damage in patients with Meniere disease]. 61
28395489 2017
264
The Prevalence of Chronic Cerebrospinal Venous Insufficiency in Meniere Disease: 24-Month Follow-up after Angioplasty. 61
28034701 2017
265
[Intensive reading of the guidelines of diagnosis and treatment of Meniere disease and benign paroxysmal positional vertigo]. 61
28395488 2017
266
[Pilot study on the functional evaluation of vestibular otolith-organ pathway in the stage of patients with Meniere disease]. 61
28395490 2017
267
Identification of operculum and surgical results in endolymphatic sac drainage surgery. 61
27004943 2017
268
Innate immune defense in the inner ear - mucines are expressed by the human endolymphatic sac. 61
28106268 2017
269
β1- and β2-adrenergic stimulation-induced electrogenic transport by human endolymphatic sac epithelium and its clinical implications. 61
28165045 2017
270
Meniett device in meniere disease: Randomized, double-blind, placebo-controlled multicenter trial. 61
27515294 2017
271
Dizziness: Approach to Evaluation and Management. 61
28145669 2017
272
Analysis of Saccular Function With Vestibular Evoked Myogenic Potential Test in Meniere's Disease. 61
28282709 2017
273
Variable expressivity and genetic heterogeneity involving DPT and SEMA3D genes in autosomal dominant familial Meniere's disease. 61
27876815 2017
274
[The pilot study of type Ⅰ allergic reaction in Meniere's disease patients]. 61
28219165 2017
275
Repeated courses of intratympanic dexamethasone injection are effective for intractable Meniere's disease. 61
27650470 2017
276
Cochlear implantation in patients with definite Meniere's disease. 61
27783138 2017
277
[Persistent postural-perceptual dizziness]. 61
28617375 2017
278
[The peripheral vestibular disorders encountered in the routine out-patient practical work]. 61
28252586 2017
279
A Herbal Medicine, Gongjindan, in Subjects with Chronic Dizziness (GOODNESS Study): Study Protocol for a Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Clinical Trial for Effectiveness, Safety, and Cost-Effectiveness. 61
29387128 2017
280
Endolymphatic hydrops in patients with unilateral and bilateral Meniere's disease. 61
27564645 2017
281
Utilisation of multi-frequency VEMPs improves diagnostic accuracy for Meniere's disease. 61
27422626 2017
282
Tone Burst Electrocochleography for the Diagnosis of Clinically Certain Meniere's Disease. 61
28670263 2017
283
Abnormal Cervical Vestibular-Evoked Myogenic Potentials Predict Evolution of Isolated Recurrent Vertigo into Meniere's Disease. 61
28928714 2017
284
[Efficacy of intratympanic gentamicin and dexamethasone in the treatment of intractable Meniere's disease]. 61
29871195 2017
285
Regulation of Fn14 Receptor and NF-κB Underlies Inflammation in Meniere's Disease. 61
29326686 2017
286
[Simultaneous triple semicircular canal plugging and cochlear implantation in advanced Meniere's disease]. 61
28104012 2017
287
Imaging of the saccule for the diagnosis of endolymphatic hydrops in Meniere disease, using a three-dimensional T2-weighted steady state free precession sequence: accurate, fast, and without contrast material intravenous injection. 61
29708183 2017
288
[The surgical treatment discussion in intractable Meniere's disease: lateral and posterior semicircular canal plugging with endolymphatic sac decompression]. 61
29871202 2017
289
Apical hair cell degeneration causes the increase in the amplitude of summating potential. 61
27424625 2016
290
Perilymph pharmacokinetics of locally-applied gentamicin in the guinea pig. 61
27725177 2016
291
Histopathology of Meniere's disease. 61
28286401 2016
292
Triple semicircular canal plugging: a novel modality for the treatment of intractable Meniere's disease. 61
27434132 2016
293
SLC44A2 single nucleotide polymorphisms, isoforms, and expression: Association with severity of Meniere's disease? 61
27829169 2016
294
The change of hippocampal volume and its relevance with inner ear function in Meniere's disease patients. 61
26856304 2016
295
An epidemiological study to investigate the relationship between Meniere's disease and migraine. 61
26666684 2016
296
[Clinical Aspects of Cochlear Implantation in Meniere's Disease and After Labyrinthectomy]. 61
26990936 2016
297
10 years of Vertigo Clinic at National Hospital Abuja, Nigeria: what have we learned? 61
26961517 2016
298
Refractory episodic vertigo: role of intratympanic gentamicin and vestibular evoked myogenic potentials. 61
27068887 2016
299
Radiology Case of the Month: Acute Onset of Dizziness and Paresthesias in an Elderly Woman. 61
28045692 2016
300
Is dehydration test using isosorbide useful in Meniere's disease? 61
27348133 2016
301
Changes in endolymphatic hydrops visualized by magnetic resonance imaging after sac surgery. 61
27752909 2016
302
High jugular bulb: different osseous landmarks and their clinical implications. 61
26905075 2016
303
Distinct vestibular phenotypes in DFNA9 families with COCH variants. 61
26758463 2016
304
Characteristics of the Cochlear Symptoms and Functions in Meniere's Disease. 61
27748337 2016
305
Utility of the Frequency Tuning Measure of oVEMP in Differentiating Meniere's Disease from BPPV. 61
27718352 2016
306
[Clinical analysis of benign paroxysmal positional vertigo associated with Meniere's disease]. 61
29871157 2016
307
Pediatric sudden sensorineural hearing loss: Etiology, diagnosis and treatment in 20 children. 61
27497416 2016
308
Experiences Engaging Healthcare When Dizzy. 61
27525623 2016
309
Oxidative Stress and Low Glutathione in Common Ear, Nose, and Throat Conditions: A Systematic Review. 61
27622960 2016
310
[Analyses of prognostic factors relevant to acute low-tone sensorineural hearing loss]. 61
27666700 2016
311
Endolymphatic space size in patients with Meniere's disease and healthy controls. 61
27080254 2016
312
Volumetric measurements of the inner ear in patients with Meniere's disease using three-dimensional magnetic resonance imaging. 61
27187035 2016
313
[Application of gadolinium enhanced magnetic resonance imaging of inner ear to observe bilateral inner ears hydrops in patients with unilateral Meniere's disease]. 61
29797973 2016
314
3D reconstruction of cochlea using optical coherence tomography. 61
28269598 2016
315
Clinical application of vestibular evoked myogenic potential (VEMP). 61
26791591 2016
316
Diameter of the Medial Side of the Cochlear Aqueduct Is Narrower in Meniere's Disease: A Radiologic Analysis. 61
27716601 2016
317
Fully Endoscopic Retrosigmoid Vestibular Nerve Section for Refractory Meniere Disease. 61
27441160 2016
318
Should the clinician do the tests for benign paroxysmal positional vertigo even in the presence of spontaneous nystagmus at primary gaze? 61
27386136 2016
319
Comparison of Endolymphatic Duct Dimensions and Jugular Bulb Abnormalities Between Meniere Disease and a Normal Population. 61
27300452 2016
320
Expression of histamine receptors in the human endolymphatic sac: the molecular rationale for betahistine use in Menieres disease. 61
26208913 2016
321
[The value of area curve ratio electrocochleography in diagnosisof Meniere's disease during different periods]. 61
29798442 2016
322
Re: Meniere's disease: Importance of socioeconomic and environmental factors. 61
27038820 2016
323
HLA-Cw Allele Frequency in Definite Meniere's Disease Compared to Probable Meniere's Disease and Healthy Controls in an Iranian Sample. 61
27602337 2016
324
[Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing]. 61
29771059 2016
325
[Meniere disease and vestibular migraine]. 61
29771055 2016
326
[Value of videonystagmography and electrocochleography in prognosis prediction of patients with acute low-tone sensorineural hearing loss]. 61
29798049 2016
327
Incidence of Hypothyroidism in Meniere's Disease. 61
27437251 2016
328
Meniere's disease. 61
27170253 2016
329
Meniere's disease. 61
27170426 2016
330
Advanced Neuroimaging of Tinnitus. 61
27154611 2016
331
Treatment of Meniere's disease with intratympanic dexamethazone plus high dosage of betahistine. 61
27178513 2016
332
Frequency-Amplitude Ratio of Ocular Vestibular-Evoked Myogenic Potentials for Detecting Meniere's Disease: A Preliminary Investigation. 61
26731295 2016
333
Application of Vestibular Spontaneous Response as a Diagnostic Aid for Meniere's Disease. 61
26334355 2016
334
Genetics of vestibular disorders: pathophysiological insights. 61
27083884 2016
335
Development of a Statistical Model for the Prediction of Common Vestibular Diagnoses. 61
26913615 2016
336
Neurovestibular Compensation following Ototoxic Lesion and Labyrinthectomy. 61
27096015 2016
337
The correlation between symptoms of definite Meniere's disease and endolymphatic hydrops visualized by magnetic resonance imaging. 61
26333096 2016
338
Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere's Disease Patients. 61
27340991 2016
339
Increased Velocity Storage in Subjects with Meniere's Disease. 61
27340990 2016
340
[The significance of prophylactic migraine therapy in controlling familial Meniere's disease, a preliminary study]. 61
29871091 2016
341
[Prevalence of bilateral abnormalities of unilateral Meniére disease]. 61
27382682 2016
342
A thin line between Meniere's disease and spontaneous intracranial hypotension syndrome. 61
26827704 2016
343
[Exploration on the new diagnostic